Life Science Update
| Index | May Value | Change 12 mo. | 12 mo. High | 12 mo. Low |
| - EC BioTools | 650 | 12% | 738 | 581 |
| - EC BigPharma | 707 | 5% | 801 | 673 |
| - EC Biotech | 523 | 8% | 642 | 484 |
July 15, 2010 Update
BioTools and Biotech were down around 5% for the month while BigPharma inched up 2%. The OSI acquisition by Astellas was completed so Intermune replaces them in the Biotech index. Declines led advances 5 to 1 for BioTools and 2 to 1 in Biotech. AstraZeneca was the big winner up 12% for the month on analyst upgrades and the Crestor patent win.
EC BioIndex
- Many of the life science indices currently available are a mixture of various types of companies. In order to better assess the situation in the different segments, Eastwoods Consulting has created these price-weighted indices for the sectors of large pharmaceutical companies, biotech companies, and life science research tools companies.
- EC BioTools Index – A, ACCL, AFFX, BEC, BIO, BRKR, CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL, TECH, TMO, WAT
- EC BigPharma Index – JNJ, PFE, GSK, NVS, SNY, LUN, ABT, LLY, AZN, WYE, BMY, NVO, BAX, TEVA, KG, ROG.VX
- EC Biotech Index – AMGN, GENZ, BIIB, CEPH, GILD, BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, MEDX, THRX, HGSI, SGMO, NKTR
- Prices are taken at the close of each month.